A survey of 2,851 patients with hemochromatosis: Symptoms and response to treatment

American Journal of Medicine

Volumn 106, Issue 6, 1999, Pages 619-624

  McDonnell, Sharon M ^a   Preston, Ben L ^b   Jewell, Sandy A ^a   Barton, James C ^c   Edwards, Corwin Q ^d   Adams, Paul C ^e   Yip, Ray ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c S Iron Overload Disorders (JCB)   (United States)

^d LDS HOSPITAL   (United States)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; FEMALE; HEMOCHROMATOSIS; HUMAN; INTESTINE ABSORPTION; IRON ABSORPTION; IRON METABOLISM; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PHLEBOTOMY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMOCHROMATOSIS; HUMANS; LIFE CHANGE EVENTS; MALE; MIDDLE AGED; PHLEBOTOMY; PREVALENCE; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; UNITED STATES;

EID: 0033039405     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00120-5     Document Type: Article

References (26)

1. Troisier M. Diabete sucre. Bull Soc Anatom (Paris). 44:1871;231-235.
2. von Reckinghausen FD. Taggeblat der (62) Versammiling Deutsch Naturforscher und Atze in Heidelberg. (German) 1889:324-325.
3. Witte D.L., Crosby W.H., Edwards C.Q., Fairbanks V.F., Mitros F.A. Practice Guideline Development Task Force of the College of American Pathologists hereditary hemochromatosis . Clin Chim Acta. 245:1996;139-200.
4. Feder J.N., Penny D.M., Irrinki A., et al. A novel MHC class like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 13:1996;399-409.
5. Niederau C., Fischer R., Purschel A., Stremmel W., Haussinger D., Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 110:1996;1107-1119.
6. Cartwright GE. Hemochromatosis. In: Editors. Harrison's Textbook of Internal Medicine, 7th ed. New York: McGraw Hill, 1974:618-619.
7. McLaren C.E., Gordeuk V.R., Looker A.C., et al. Prevalence of heterozygotes for hemochromatosis in the white population of the United States. Blood. 86:1995;2021-2027.
8. Edwards C.Q., Griffen L.M., Goldgar D., Drummond C., Skolnick M.H., Kushner J.P. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. NEJM. 318:1988;1355-1362.
9. Niederau C., Niederau C.M., Lange S., et al. Screening for hemochromatosis and iron deficiency in employees and primary care patients in Western Germany. Ann Intern Med. 128:1998;337-345.
10. McDonnell S.M., Phatak P., Felitti V., Hover A.H., McClaren G. Experiences with screening for hemochromatosis in primary care. Ann Intern Med. 129:1998;962-970.
11. Bradley L.A., Haddow J.E., Palomaki G.E. Population screening for haemochromatosis a unifying analysis of published intervention trials . J Med Screen. 3:1996;178-184.
12. Adams P.C., Valberg L.S. Evolving expression of hereditary hemochromatosis. Semin Liver Dis. 16:1996;47-54.
13. Adams P.C., Deugnier Y., Moirand R., Brissot P. The relationship between iron overload, clinical symptoms and age in 410 hemochromatosis patients. Hepatology. 25:1997;162-166.
14. Niederau C., Fischer R., Purschel A., Stremmel W., Haussingr D. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 110:1996;1107-1119.
15. Gable C.B. Hemochromatosis and dietary iron supplementation implications from U.S. mortality, morbidity and health survey data . J Am Diet Assoc. 92:1992;208-212.
16. Adams P.C., Valberg L.S. Evolving expression of hereditary hemochromatosis. Semin Liver Dis. 16:1996;47-54.
17. Edwards C.Q., Cartwright G.E., Skolnick M.H., Amos D.B. Homozygosity for hemochromatosis clinical manifestations . Ann Intern Med. 93:1980;519-525.
18. Cogswell M.E., McDonnell S.M., Khoury M.J., Franks A.L., Burke W., Brittenham G. Iron overload, public health and genetics evaluating the evidence for hemochromatosis screening . Ann Intern Med. 129:1998;971-979.
19. Plan and operation of the second National Health and Nutrition Examination Survey, 1976-1980. Vital Health Statistics. 1:1981;69.
20. National Center for Health Statistics. Plan and operation of the third National Health and Nutrition Examination Survey, 1988-1994. Vital Health Statistics. 1(32), 1994. DHHS Publ. No. (PHS) 94-1308.
21. Dean A.G., Dean J.A., Coulombier D., et al. Epi Info, Version 6 a word processing, database, and statistics program for public health on IBM-compatible microcomputers . 1995;Centers for Disease Control and Prevention, Atlanta.
22. McDonnell S.M., Witte D., McIntyre R., Cogswell M.E. Strategies to increase case detection of hemochromatosis. Ann Intern Med. 129:1998;987-992.
23. Barton J.C., McDonnell S.M., Adams P.C., et al. Management of hemochromatosis recommendations of a CDC working group . Ann Intern Med. 129:1998;932-939.
24. Swanson AB, de Groot Swanson G. Osteoarthritis in the hand. Clin Rheum Dis. 1985;11:393-420. Review.
25. Chaisson C.E., Zhang Y., McAlindon T.E., et al. Radiographic hand osteoarthritis incidence, patterns, and influence of pre-existing disease in a population based sample . J Rheumatol. 24:1997;1337-1343.
26. Moirand R., Adams P.C., Bicheler V., Brissot P., Deugnier Y. Clinical features of genetic hemochromatosis in women compared with men. Ann Intern Med. 127:1997;105-110.